Data from the ASCENT study of LIQ861 (YUTREPIAâ„¢) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk distance, cardiac effort and quality of life - Case study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback